Re-evaluation of the functional anatomy of the basal ganglia. In normal and Parkinsonian states

Neuroscience

Volumn 76, Issue 2, 1997, Pages 335-343

  Levy, R ^a   Hazrati, L N ^b   Herrero, M T ^a,c   Vila, M ^a   Hassani, O K ^d   Mouroux, M ^d   Ruberg, M ^a   Asensi, H ^c   Agid, Y ^a   Feger J ^d   Obeso, J A ^e   Parent, A ^b   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c UNIVERSITY OF MURCIA   (Spain)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HOSPITAL QUIRÓN   (Spain)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Cytochrome oxidase; Glutamate decarboxylase; Pallidum; Parkinson's disease; Subthalamic nucleus

Indexed keywords

CYTOCHROME C OXIDASE; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; GABAERGIC SYSTEM; GLOBUS PALLIDUS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MONKEY; NEUROANATOMY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SUBTHALAMIC NUCLEUS;

EID: 0031023394     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00409-5     Document Type: Note

References (68)

1. Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-376.
2. Baran H., Lassman H. and Hornykiewicz O. (1988) Behavioral and neurochemical changes 6 months after kainic acid. Soc. Neurosci. Abstr. 14, 472.
3. Blanchet P. J., Boucher R. and Bedard P. J. (1994) Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys. Brain Res. 650, 32-39.
4. Blandini F. and Greenamyre J. T. (1995) Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal ganglia. Brain Res. 669, 59-66.
5. Campbell G. A., Eckardt M. J. and Weight F. F. (1985) Dopaminergic mechanisms in subthalamic nucleus of the rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333, 261-270.
6. Canteras N. S., Shammah-Lagnado S. J., Silva B. and Ricardo J. A. (1990) Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513, 43-59.
7. Chergui K., Nomikos G. G., Mathé J. M., Gonon F. and Svensson T. H. (1996) Burst stimulation of the medial forebrain bundle selectively increases Fos immunoreactivity in the limbic forebrain of the rat. Neuroscience 72, 141-151.
8. Chesselet M. F., Weiss L., Wuenschell C., Tobin A. J. and Affolter H. U. (1987) Comparative distribution of RNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J. comp. Neurol. 262, 125-140.
9. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
10. Drengler S. M. and Oltmans G. A. (1993) Rapid increases in cerebellar Purkinje cell glutamic acid decarboxylase (GAD67) mRNA after lesion-induced increases in cell firing. Brain Res. 615, 175-179.
11. Feldblum S., Erlander M. G. and Tobin A. J. (1993) Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 34, 689-706.
12. Filion M. (1979) Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of the globus pallidus neurons in awake monkey. Brain Res. 178, 425-441.
13. Filion M. and Tremblay L. (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced Parkinsonism. Brain Res. 547, 142-151.
14. Fontaine B., Sassoon D., Buckingham M. and Changeux J. P. (1988) Detection of the nicotinic acetylcholine receptor subunit mRNA by in situ hybridization at neuromuscular junction of 15-day old chick striatal muscles. Eur. molec. Biol. Org. J. 7, 603-609.
15. Gale K. and Casu M. (1981) Dynamic utilization of GABA in the substantia nigra: regulation by dopamine and GABA in the striatum and its clinical and behavioral implications. Molec. cell. Biochem. 39, 369-405.
16. Gonon F. G. (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24, 19-28.
17. Guridi J., Herrero M.-T., Luquin M. R., Guillén J., Ruberg M., Vila M., Laguna J., Javoy-Agid F., Agid Y. and Hirsch E. C. and Obeso J. A. (1996) Subthalamotomy in parkinsonian monkeys: behavioral and biochemical analysis. Brain (in press).
18. Hamada I. and DeLong M. R. (1992) Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J. Neurophysiol. 68, 1859-1866.
19. Hassani O. K., Mouroux M. and Féger J. (1996) Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72, 105-115.
20. Hazrati L.-N. and Parent A. (1992) Convergence of subthalamic and striatal efferents at pallidal level in primates. Brain Res. 569, 336-340.
21. Hazrati L.-N. and Parent A. (1992) Differential patterns of arborization of striatal and subthalamic fibers in the two pallidal segments in primates. Brain Res. 598, 311-315.
22. Hazrati L.-N. and Parent A. (1993) The anatomical organization of the striatal and subthalamic afferents at the pallidal level in primates. Prog. Brain Res. 99, 89-104.
23. Hendry S. H. (1991) Delayed reduction in GABA and GAD immunoreactivity in the adult monkey dorsal lateral geniculate nucleus following monocular deprivation or enucleation. Expl Brain Res. 86, 47-59.
24. Herrero M. T., Levy R., Ruberg M., Javoy-Agid F., Luquin M. R., Agid Y., Hirsch E. C. and Obeso J. A. (1996) Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkeys and patients with Parkinson's disease. Adv. Neurol. 69, 209-216.
25. Herrero M. T., Levy R., Ruberg M., Luquin M. R., Villares J., Guillen J., Faucheux B., Javoy-Agid F., Guridi J., Agid Y., Obeso J. A. and Hirsch E. C. (1996) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47, 219-224.
26. Herrero M. T., Ruberg M., Hirsch E. C., Mouatt A., Tobin A. J., Agid Y., Obeso J. A. and Javoy-Agid F. (1993) In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neurosci. Lett. 157, 57-61.
27. +-ATPase. Neurosci. Lett. 138, 188-192.
28. Hevner R. F. and Wong-Riley M. T. T. (1991) Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci. 11, 1942-1958.
29. Johnson A. E., Coirini H., Källström L. and Wiesel F. A. (1994) Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport 5, 1836-1838.
30. Kincaid A. E., Albin R. L., Newman S. W., Penney J. B. and Young A. B. (1992) 6-Hydroxydopamine lesions of the nigrostriatal pathway alter expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience 51, 705-718.
31. Kincaïd A. E., Penney J. B., Young A. B. and Newman S. W. (1991) The globus pallidus receives a projection from the parafascicular nucleus in rat. Brain Res. 553, 18-26.
32. Kita H. and Kitai S. T. (1991) Intracellular study of the rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res. 564, 296-305.
33. Kitai S. T. and Kita H. (1987) Anatomy and physiology of subthalamic nucleus: a driving force of the basal ganglia. In The Basal Ganglia II: Structure and Function: Current Concepts (eds Carpenter M. B. and Jayaraman A.), pp. 357-373. Plenum Press, New York.
34. Kreiss D. S., Anderson L. A. and Walters J. R. (1995) Subthalamic nucleus neuronal activity is increased by dopamine D1 receptor agonists. Soc. Neurosci. Abstr. 21, 914.
35. Levy R., Herrero M. T., Ruberg M., Villares J., Faucheux B., Guridi J., Guillen J., Luquin M. R., Javoy-Agid F., Obeso J. A., Agid Y. and Hirsch E. C. (1995) Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons of the striatum in MPTP-treated monkeys and Parkinson's disease. Eur. J. Neurosci. 7, 1199-1209.
36. Lindefors N., Brodin E., Tossman U., Segovia J. and Ungerstedt U. (1989) Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Expl Brain Res. 74, 527-534.
37. Litwak J., Mercugliano M., Oltmans G. A. and Chesselet M. F. (1990) Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cells firing. Neurosci. Lett. 116, 179-183.
38. Lutes J., Lorden J. F., Davis B. J. and Oltmans G. A. (1992) GABA levels and GAD immunoreactivity in the deep cerebellar nuclei of rats with altered olivo-cerebellar function. Brain Res. Bull. 29, 329-336.
39. Marksteiner J. and Sperk G. (1988) Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decrease seizure threshold. Neuroscience 26, 379-385.
40. Martin D. L. and Rimvall K. (1993) Regulation of gamma-aminobutyric acid synthesis in the brain. J. Neurochem. 60, 395-407.
41. Miller W. C. and DeLong M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of Parkinsonism. In The Basal Ganglia II: Structure and Function: Current Concepts (eds Carpenter M. B. and Jayaraman A.), pp. 415-427. Plenum, New York.
42. Mink J. W. and Thach W. T. (1993) Basal ganglia intrinsic circuits and their role in behavior. Curr. Opin. Neurobiol. 3, 950-957.
43. Mintz I., Hammond C. and Féger J. (1986) Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res. 375, 172-175.
44. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D., Sambrook M. A. and Crossman A. R. (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32, 213-226.
45. Montgomery E. B., Buchholz S. R., Delitto A. and Collins R. C. (1985) Effects of MPTP on basal ganglia physiology in monkeys. Soc. Neurosci. Abstr. 11, 1161.
46. Mouroux M. and Féger J. (1993) Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic. NeuroReport 4, 613-615.
47. Mouroux M., Hassani O. K. and Féger J. (1995) Electrophysiological study of the excitatory parafascicular projection to the subthalamic nucleus and evidence for ipsi-and contralateral controls. Neuroscience 67, 399-407.
48. Pan H. S. and Walters J. R. (1988) Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in rat. Synapse 2, 650-656.
49. Parent A. and Hazrati L. N. (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20, 128-154.
50. Parent A. and Lavoie B. (1993) Dopaminergic innervation of the basal ganglia in normal and parkinsonian monkeys. In Current Concepts in Parkinson's Disease Research (eds Schneider J. S. and Gupta M.), pp. 403-414. Hans Huber, Toronto.
51. Porrino L. J., Burns R. S., Crane A. M., Palombo E., Kopin I. J. and Sokoloff L. (1987) Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine-induced Parkinsonism in monkeys. Proc. natn. Acad. Sci. U. S. A. 84, 5995-5999.
52. Robledo P. and Feger J. (1990) Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and pallidal complex: electrophysiological data. Brain Res. 518, 47-54.
53. Ruskin D. N. and Marshall J. F. (1995) D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and 6-OHDA-lesioned rats. Soc. Neurosci. Abstr. 21, 1906.
54. Sadikot A. F., Parent A. and François C. (1992) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J. comp. Neurol. 315, 137-159.
55. Schwartz W. J., Smith C. B., Davidsen L., Savaki H., Sokoloff L., Mata M., Fink D. J. and Gainer H. (1979) Metabolic mapping of functional activity in the hypothalamo-neurohypophysal system of the rat. Science 205, 723-725.
56. Schwartzman R. J., Alexander G. M., Ferraro T. N. and Grothusen J. R. (1988) Cerebral metabolism of parkinsonian primates 21 days after MPTP. Expl Neurol. 102, 307-313.
57. Segovia J. and Garcia-Munoz M. (1987) Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation. Neuropsychopharmacology 26, 1449-1451.
58. Segovia J., Tillakaratne N. J. K., Whelan K., Tobin A. J. and Gale K. (1990) Parallel increases in striatal glutamic acid decarboxylase and mRNA levels in rats with lesions of nigrostriatal pathway. Brain Res. 529, 345-348.
59. Shink E. and Smith Y. (1995) Differential synaptic innervation of neurons in the internal and external segments of the globus pallidus by the GABA-and glutamate-containing terminals in the squirrel monkey. J. comp. Neurol. 358, 119-141.
60. Smith Y. and Parent A. (1988) Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 453, 353-356.
61. Smith Y., Wichmann T. and DeLong M. R. (1994) Synaptic innervation of neurones in the internal pallidal segment by the subthalamic nucleus and the external pallidum in monkeys. J. comp. Neurol. 343, 297-318.
62. Soghomonian J. J. and Chesselet M. F. (1992) Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopedoncular nucleus of the rat. Synapse 11, 124-133.
63. Soghomonian J. J., Pednault S., Audet G. and Parent A. (1994) Increased glutamate decarboxylase mRNA level in the striatum and pallidum of MPTP-treated primates. J. Neurosci. 14, 6256-6265.
64. Vila M., Herrero M. T., Levy R., Faucheux B., Ruberg M., Guillen J., Luquin M. R., Guridi J., Javoy-Agid F., Agid Y., Obeso J. A. and Hirsch E. C. (1996) Consequences of nigrostriatal denervation on the GABAergic neurons of substantia nigra pars reticulata and superior colliculus in Parkinsonian syndromes. Neurology 46, 802-809.
65. Vila M., Levy R., Herrero M. T., Faucheux B., Obeso J. A., Agid Y. and Hirsch E. C. (1996) Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non human primates: a cytochrome oxidase histochemistry study. Neuroscience 71, 903-912.
66. Wichmann T. and DeLong M. R. (1993) Pathophysiology of Parkinsonian motor abnormalities. In Advances in Neurology (eds Narabayashi H., Nagatsu T., Yanagisawa N. and Mizuno Y.), Vol. 60, pp. 53-61. Raven Press, New York.
67. Wong-Riley M. T. T. (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12, 94-101.
68. Yarowsky P., Crane A. and Sokoloff L. (1985) Metabolic activation of specific postsynaptic elements in superior cervical ganglion by antidromic stimulation of the external carotid nerve. Brain Res. 334, 330-334.